Leptomeningeal Contrast Enhancement Is Associated with Disability Progression and Grey Matter Atrophy in Multiple Sclerosis

Leptomeningeal contrast enhancement (LMCE) on magnetic resonance imaging (MRI) is a newly recognized possible biomarker in multiple sclerosis (MS), associated with MS progression and cortical atrophy. In this study, we aimed to assess the prevalence of LMCE foci and their impact on neurodegeneration...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neurol Res Int
Hlavní autoři: Makshakov, Gleb, Magonov, Evgeniy, Totolyan, Natalia, Nazarov, Vladimir, Lapin, Sergey, Mazing, Alexandra, Verbitskaya, Elena, Trofimova, Tatiana, Krasnov, Vladimir, Shumilina, Maria, Skoromets, Alexander, Evdoshenko, Evgeniy
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2017
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5643086/
https://ncbi.nlm.nih.gov/pubmed/29291134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8652463
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky